Results 61 to 70 of about 197,741 (365)

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

Nature Communications, 2022
The recent emergence of the Omicron variant has raised concerns on vaccine efficacy and the urgent need to study more efficient vaccination strategies. Here we observed that an mRNA vaccine booster in individuals vaccinated with two doses of inactivated ...
F. Zuo, Hassan Abolhassani, Likun Du, A. Piralla, F. Bertoglio, L. de Campos-Mata, H. Wan, M. Schubert, I. Cassaniti, Yating Wang, J. Sammartino, R. Sun, S. Vlachiotis, F. Bergami, M. Kumagai-Braesch, J. Andréll, Zhao-xia Zhang, Yintong Xue, E. Wenzel, L. Calzolai, L. Varani, N. Rezaei, Z. Chavoshzadeh, F. Baldanti, M. Hust, L. Hammarström, H. Marcotte, Q. Pan-Hammarström   +27 more
semanticscholar   +1 more source

Friend or foe—The Pfizer‐BioNTech (BNT162b2) vaccination: A case report of reversible acute acalculous cholecystitis

Clinical Case Reports, 2022
We described a rare case of vaccine‐induced acalculous cholecystitis (ACC). A 52‐year‐old female developed ACC after 8 h of receiving a 3rd dose of the Pfizer‐BioNTech COVID‐19 vaccination. The symptoms subsided completely with conservative treatment for
Bianca Maria Wahlen, Ruben Peralta, Hassan Al‐Thani, Ayman El‐Menyar   +3 more
doaj   +1 more source

JUWELS Cluster and Booster: Exascale Pathfinder with Modular Supercomputing Architecture at Juelich Supercomputing Centre

Journal of large-scale research facilities JLSRF, 2021
JUWELS is a multi-petaflop modular supercomputer operated by Juelich Supercomputing Centre at Forschungszentrum Juelich as a European and national supercomputing resource for the Gauss Centre for Supercomputing.
Damián Alvarez
semanticscholar   +1 more source

Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial

Vaccines
Vaccination remains an important mitigation tool against COVID-19. We report 1-month safety and preliminary immunogenicity data from a substudy of an ongoing, open-label, phase 2/3 study of monovalent Omicron XBB.1.5-adapted BNT162b2 (single 30-μg dose).
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, Xia Xu, Vishva Bangad, Federico Mensa, Jing Zou, Xuping Xie, Yanping Hu, Claire Lu, Mark Cutler, Todd Belanger, David Cooper, Kenneth Koury, Annaliesa S. Anderson, Özlem Türeci, Uǧur Şahin, Kena A. Swanson, Kayvon Modjarrad, Alejandra Gurtman, Nicholas Kitchin   +20 more
doaj   +1 more source

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022

Emerging Infectious Diseases, 2023
The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey–Adult COVID Module collected during February 27–March 26, 2022 to assess ...
P. Lu, A. Srivastav, K. Vashist, C. Black, J. Kriss, M. Hung, L. Meng, T. Zhou, D. Yankey, N. Masters, H. Fast, H. Razzaghi, J. Singleton   +12 more
semanticscholar   +1 more source

Misuse of booster seats [PDF]

Injury Prevention, 2000
Objective—To describe several aspects of booster seat use and misuse in a sample of children attending child safety seat clinics. Methods—Booster seat practices were assessed at 76 child safety seat clinics held between April 1997 and January 1999 in Pennsylvania and southern New Jersey.
S D, Morris, K B, Arbogast, D R, Durbin, F K, Winston   +3 more
openaire   +2 more sources

Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults — United States, November 1–December 10, 2022

MMWR. Morbidity and mortality weekly report, 2023
Bivalent COVID-19 booster vaccines, developed to protect against both ancestral and Omicron BA.4/BA.5 variants, are recommended to increase protection against SARS-CoV-2 infection and severe disease* (1,2). However, relatively few eligible U.S.
Alyssa H. Sinclair, Morgan K. Taylor, J. Weitz, S. Beckett, G. Samanez-Larkin   +4 more
semanticscholar   +1 more source

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele, Calogero Virgone, Michaela Kuhlen, Sabine Irtan, Yves Reguerre, Malgorzata Krawczyk, Ewa Bien, Tal Ben‐Ami, Maja Cesen, Ricardo Lopez‐Almaraz, Andrea Ferrari, Gianni Bisogno, Dominik T. Schneider, Abbas Agaimy, Constantin Lapa, Hubert Ducou le Pointe, Rainer Claus, Catherine Daniel, Ines B. Brecht, Daniel Orbach   +19 more
wiley   +1 more source

PHS Booster - Articles [PDF]

, 1930
Digital reproduction of microfilmed articles and Nellie\u27s Nook sections of The Booster, a Pittsburg High School publication, from the years 1930-1949.https://digitalcommons.pittstate.edu/nellydonpubs/1002/thumbnail ...
The Booster,
core  

Immune response in cattle vaccinated against rabies [PDF]

Memorias do Instituto Oswaldo Cruz, 2000
In order to determine the best type of rabies vaccine to use as a booster, 78 serological samples from singly vaccinated cattle were analyzed by counterimmunoelectrophoresis technique.
Alexandre Nunes de Oliveira, Márcia Cristina Ribeiro Andrade, Marlon Vicente da Silva, Wlamir Corrêa de Moura, Ellen Cortez Contreiras   +4 more
doaj   +1 more source